India to South Africa: Acyclovir Export Trade Route
India has recorded 47 verified shipments of Acyclovir exported to South Africa, representing a combined trade value of $1.1M USD. This corridor is served by 17 active Indian exporters, with an average shipment value of $23.4K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 46% of total export value with 9 shipments worth $511.2K USD. On the buying side, MEDPRO PHARMACEUTICA (PTY) LTD is the largest importer in South Africa with $353.5K USD in purchases. The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , J B CHEMICALS AND PHARMACEUTICALS LIMITED — together control 95% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to South Africa Acyclovir corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $1.1M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's acyclovir manufacturing sector.
Across 17 active suppliers, the average shipment value stands at $23.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with acyclovir's non-urgent bulk-order profile.
Shipment activity peaks during July-September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 15.8%, placing it at rank #12 among India's top acyclovir export destinations globally.
On the import side, key buyers of Indian acyclovir in South Africa include MEDPRO PHARMACEUTICA (PTY) LTD , MEDPRO PHARMACEUTICA (PTY) LTD, MEDPRO PHARMACEUTICA PTY LTD and 23 others. MEDPRO PHARMACEUTICA (PTY) LTD is the single largest importer with 5 shipments valued at $353.5K USD.
